ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$12.96
Tradestie Score
50
Market Cap
$226.82M
Revenue Growth
-0.2%
Analyst Upside
+68.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.67
|
$407.71M | - | 52 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$12.34
|
$386.68M | - | 73 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.09
|
$382.04M | - | 61 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.77
|
$371.64M | - | 51 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$8.95
|
$357.51M | - | 49 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.51
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$36.99
|
$353.70M | - | 64 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.72
|
$350.98M | - | 55 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.74
|
$341.56M | - | 37 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.19
|
$332.96M | - | 69 | Compare |
More ENTA Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry